These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6822139)

  • 21. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
    Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.
    Sánchez RA; Marcó E; Gilbert HB; Raffaele P; Brito M; Giménez M; Moledo LI
    Drugs; 1985; 30 Suppl 1():49-58. PubMed ID: 2994987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-related changes in autonomic control: the use of beta blockers in the treatment of hypertension.
    Collins KJ
    Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1257-62. PubMed ID: 1672602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations in neural cardiovascular control mechanisms with ageing.
    Giannattasio C; Ferrari AU; Mancia G
    J Hypertens Suppl; 1994 Sep; 12(6):S13-7. PubMed ID: 7799104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neurohumoral mechanisms regulating renal blood circulation in patients with hypertension undergoing captopril block of angiotensin-converting enzyme].
    Almazov VA; Ametov AS; Shliakhto EV; Dolgova IB; Pushkarev AA
    Ter Arkh; 1989; 61(8):13-5. PubMed ID: 2573961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Volume control and altered renal and adrenal responsiveness to angiotensin in essential hypertension: implications for treatment with converting enzyme inhibition.
    Hollenberg NK; Williams GH
    J Hypertens Suppl; 1983 Oct; 1(1):119-28. PubMed ID: 6100600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin type 2 receptor stimulation increases renal function in female, but not male, spontaneously hypertensive rats.
    Hilliard LM; Chow CL; Mirabito KM; Steckelings UM; Unger T; Widdop RE; Denton KM
    Hypertension; 2014 Aug; 64(2):378-83. PubMed ID: 24842923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin-converting enzyme inhibition in patients with essential hypertension.
    Kramer HJ; Predel HG; Meyer-Lehnert H
    Clin Physiol Biochem; 1990; 8 Suppl 1():16-24. PubMed ID: 2257720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal function and hemodynamic studies in low- and normal-renin essential hypertension.
    Bauer JH; Brooks CS; Burch RN
    Arch Intern Med; 1982 Jul; 142(7):1317-23. PubMed ID: 7046671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aldosterone Contributes to Sympathoexcitation in Renovascular Hypertension.
    Lincevicius GS; Shimoura CG; Nishi EE; Perry JC; Casarini DE; Gomes GN; Bergamaschi CT; Campos RR
    Am J Hypertens; 2015 Sep; 28(9):1083-90. PubMed ID: 25628418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multifactorial evaluation of blood pressure fall upon hospitalization in essential hypertensive patients.
    Nishimura H; Nishioka A; Kubo S; Suwa M; Kino M; Kawamura K
    Clin Sci (Lond); 1987 Aug; 73(2):135-41. PubMed ID: 3652621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of renal hemodynamics.
    Hall JE
    Int Rev Physiol; 1982; 26():243-321. PubMed ID: 6921176
    [No Abstract]   [Full Text] [Related]  

  • 33. Recombinant erythropoietin acutely decreases renal perfusion and decouples the renin-angiotensin-aldosterone system.
    Aachmann-Andersen NJ; Christensen SJ; Lisbjerg K; Oturai P; Johansson PI; Holstein-Rathlou NH; Olsen NV
    Physiol Rep; 2018 Mar; 6(5):. PubMed ID: 29504258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic aspects of essential hypertension in humans.
    Conway J
    Physiol Rev; 1984 Apr; 64(2):617-60. PubMed ID: 6369352
    [No Abstract]   [Full Text] [Related]  

  • 35. Renal BOLD-MRI relates to kidney function and activity of the renin-angiotensin-aldosterone system in hypertensive patients.
    Vink EE; de Boer A; Hoogduin HJ; Voskuil M; Leiner T; Bots ML; Joles JA; Blankestijn PJ
    J Hypertens; 2015 Mar; 33(3):597-603; discussion 603-4. PubMed ID: 25479032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term antihypertensive effects of aliskiren, a direct renin inhibitor, in chronic hemodialysis patients.
    Ishimitsu T; Ohta S; Ohno E; Takahashi T; Numabe A; Okamura A; Ohba S; Hashimoto A; Matsuoka H
    Ther Apher Dial; 2013 Oct; 17(5):524-31. PubMed ID: 24107281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute hemodynamic (systemic and renal) and humoral effects of three increasing doses of iloprost in essential hypertensives.
    Arzilli F; Giovannetti R; Lenzi M; Salvetti A
    Am J Hypertens; 1989 Nov; 2(11 Pt 1):856-60. PubMed ID: 2480147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic and renal effects of indomethacin in losartan-treated hypertensive individuals.
    Olsen ME; Thomsen T; Hassager C; Ibsen H; Dige-Petersen H
    Am J Hypertens; 1999 Feb; 12(2 Pt 1):209-16. PubMed ID: 10090350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of antihypertensive, renal hemodynamic, and humoral effects of pinacidil and hydralazine monotherapy.
    Abraham PA; Halstenson CE; Matzke GR; Keane WF
    J Clin Hypertens; 1987 Dec; 3(4):439-51. PubMed ID: 3330986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of antihypertensive drugs on the renin-angiotensin system.
    Johnston CI
    Drugs; 1976; 12(4):274-91. PubMed ID: 786609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.